Investigation of the brain pathophysiology of addiction disorder and evaluation of the treatment effect of neuromodulatio
- Conditions
- Mental and behavioral disorders
- Registration Number
- KCT0002823
- Lead Sponsor
- The Catholic University of Korea, Incheon St. Mary's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
[Alcohol use disorder group]
(a) Diagnosed with alcohol use disorder based on the Diagnostic and Statistical Manual of Mental Disorders-5 and taking standard medication, and alcohol abstinence status will be considered.
(b) Adult men and women aged 20 to 60 years
[Problematic drinking group]
(a) More than 4 standard drinks (SD) for one occasion or more than 14 SD for one week (men) / More than 3 SD for one occasion or more than 7 SD for one week (women) or scores of 8 or more on Alcohol Use Disorders Identification Test (AUDIT) for men / scores of 6 of more on AUDIT for women
(b) Adult men and women aged 20 to 60 years
[Normal control group]
(a) Adult men and women aged 20 to 60 years
Exclusion criteria
(a) Have major medical, neurological, or psychiatric illnesses
(b) Pregnant, lactation, or have a pregnancy plan
(c) Not compatible for MRI and PET-CT (internal metal and medical devices, claustrophobia, etc.)
(d) History of seizures
(e) Problems with stimulation electrodes due to deformity of the scalp, inflammation reaction or other dermatological problems
(f) History of cancer in the past three years
(g) Surgery for brain vessels such as brain surgery or carotid surgery
(h) Dyspnea when sitting still
(i) Loss of consciousness for more than one hour due to other causes other than general anesthesia
(j) Have been hospitalized for a head injury
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alcohol use disorder symptoms such as cravings assessed by self-report questionnaire;Maintenance of abstinence from alcohol
- Secondary Outcome Measures
Name Time Method Changes in structure, function, and metabolism of the brain evaluated using MRI and PET;Changes in depressive symptoms assessed by self-report questionnaire;Changes in anxiety symptoms assessed by self-report questionnaire;Changes in cognitive function evaluated by neuropsychological tests